A pilot study investigating the safety and feasibility of embolising the left gastric artery to aid rapid weight-loss in morbidly obese patients awaiting elective surgery.

I-MED Radiology Network0 个研究点目标入组 1 人开始时间: 2021年2月1日最近更新: 2024年7月15日

适应症

试验速览

暂无简介。

•BMI over 35 and weight <200 kg awaiting elective surgery, non-bariatric operative candidates; adequate renal, hepatic and haematologic function; able to undergo an angiographic procedure; medically fit enough to undertake mild or moderate exercise, motivated to lose weight and adhere to prescribed dietary advice. Further, patients must have private health insurance to be included in this trial.; BMI over 35 and weight <200 kg awaiting elective surgery, non-bariatric operative candidates; adequate renal, hepatic and haematologic function; able to undergo an angiographic procedure; medically fit enough to undertake mild or moderate exercise, motivated to lose weight and adhere to prescribed dietary advice. Further, patients must have private health insurance to be included in this trial.

•Malignancy; pregnancy; active H. pylori infection; autoimmune disease; history of inflammatory bowel disease; eGFR <35; allergy to intravenous contrast; severe cardiopulmonary dysfunction; serious mental health or mood modulating medication; previous oesophageal or gastric surgery; planned or interest in future bariatric surgery.; Malignancy; pregnancy; active H. pylori infection; autoimmune disease; history of inflammatory bowel disease; eGFR <35; allergy to intravenous contrast; severe cardiopulmonary dysfunction; serious mental health or mood modulating medication; previous oesophageal or gastric surgery; planned or interest in future bariatric surgery.

发起方

I-MED Radiology Network